Haldar, Koirobi
George, Leena
Wang, Zhang
Mistry, Vijay
Ramsheh, Mohammadali Yavari
Free, Robert C.
John, Catherine
Reeve, Nicola F.
Miller, Bruce E.
Tal-Singer, Ruth
Webb, Adam J.
Brookes, Anthony J.
Tobin, Martin D.
Singh, Dave
Donaldson, Gavin C.
Wedzicha, Jadwiga A.
Brown, James R.
Barer, Michael R.
Brightling, Christopher E. http://orcid.org/0000-0002-9345-4903
Funding for this research was provided by:
Medical Research Council (COPDMaP)
Airprom (FP7-270194)
Article History
Received: 9 April 2020
Accepted: 8 July 2020
First Online: 14 July 2020
Ethics approval and consent to participate
: All patients provided written informed consent using protocols approved by the local Ethics Committees at each site (London- 11/L0/1630; Manchester- 10/H/1003/108; Leicester- 07/H0406/157) for COPDMAP study and the EXCEED study ethics number is: 13/EM/0226.
: Not applicable.
: KH, LG, ZW, VM, MYR, RCF, NFR, AJW, AJB, MRB have nothing to declare. JRB, BEM and RTS are employees and shareholders of GSK; GCD reports grants and personal fees from Astrazeneca and grants from Micom ltd and American Thoracic Society; MDT reports grants from GSK and other from Orion; JAW reports grants from GSK, grants from Johnson and Johnson, other from Novartis, other from Boehringer Ingelheim, other from Astra Zeneca, other from GSK, grants from GSK, grants from Astra Zeneca, grants from Boehringer Ingelheim, grants from Novartis; DS reports grants and personal fees from GlaxoSmithKline, grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingleheim, grants and personal fees from Chiesi, personal fees from Cipla, personal fees from Genentech, grants and personal fees from Glenmark, grants and personal fees from Menarini, grants and personal fees from Mundipharma, grants and personal fees from Novartis, personal fees from Peptinnovate, grants and personal fees from Pfizer, grants and personal fees from Pulmatrix, grants and personal fees from Therevance, grants and personal fees from Verona; CEB reports grants and personal fees from GSK, grants and personal fees from Novartis, grants and personal fees from Genentech, grants and personal fees from Chiesi, personal fees from Sanofi/Regeneron, grants and personal fees from 4DPharma, grants and personal fees from BI, grants and personal fees from Mologics, grants and personal fees from Gossamer, grants and personal fees from AZ/MedImmune, grants and personal fees from TEVA, outside the submitted work. CEB reports grants from MRC COPDMAP, grants from AirPROM (FP7–270194), during the conduct of the study.